GLUTAMINE REQUIREMENTS IN THE GENERATION OF LYMPHOKINE-ACTIVATED KILLER-CELLS

被引：39

作者：

JURETIC, A

SPAGNOLI, GC

HORIG, H

BABST, R

VONBREMEN, K

HARDER, F

HEBERER, M

机构：

[1] Departments of Surgery and Research, University of Basel, CH-4031 Basel, ZLF 401

来源：

CLINICAL NUTRITION | 1994年 / 13卷 / 01期

关键词：

D O I：

10.1016/0261-5614(94)90009-4

中图分类号：

R15 [营养卫生、食品卫生]; TS201 [基础科学];

学科分类号：

100403 ;

摘要：

The role of glutamine (GLN) in the generation of lymphokine-activated killer (LAK) cell activity was investigated. LAK cells were derived from healthy donors and peripheral blood mononuclear cells (PBMC) were obtained using either unseparated PMBC or DR- CD3- CD16+ CD56+ enriched cells. PBMC were cultured for 6 or 10 days in medium supplemented with recombinant interleukin-2 (rIL-2; 100 U/ml) in the presence of different concentrations of GLN. K562 (natural killer-NK-sensitive targets), 1301 and U-937 (NK-resistant targets) cells were used as targets in the cytotoxic assays. Furthermore, the limiting dilution (LD) culture system was applied as an alternative to the bulk cell culture system. It was found that GLN affects the lytic potential of cultured cells while the frequency of responding cells did not significantly differ between the compared cell cultures performed in the presence of different amounts of GLN. Data on cell proliferation with IL-2 stimulation showed significant differences in cultures performed in the presence or absence of GLN. The results of present investigation suggest a supportive role of GLN in the generation of LAK cells. GLN deficit affects LAK cell killing activity by limiting the number of generated effector cells while acquisition of broad-range killing capacity was not affected.

引用

页码：42 / 49

页数：8

共 40 条

[1] Grimm, Mazumder, Zhang, Rosenberg, Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes, J Exp Med, 155, pp. 1823-1841, (1982)
[2] Grimm, Robb, Roth, Et al., Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells, J Exp Med, 158, pp. 1356-1361, (1983)
[3] Lotze, Grimm, Mazumder, Strausser, Rosenberg, Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor, Cancer Res, 41, pp. 4420-4425, (1981)
[4] Hersey, Bindon, Edwards, Murray, Phillips, McCarthy, Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2, Int. J Cancer, 28, pp. 695-703, (1981)
[5] Parkinson, Lotzova, Interleukin-2, killer cells and cancer therapy: an overview, Nat Immun Cell Growth Regul, 9, pp. 237-241, (1990)
[6] Whiteside, Cancer therapy with tumor-infiltrating lymphocytes: evaluation of potential and limitations, In vivo, 5, pp. 553-560, (1991)
[7] Guillou, Immunotherapy for cancer, Br J Surg, 78, pp. 1281-1282, (1991)
[8] Rosenberg, The immunotherapy and gene therapy of cancer, J Clin Oncol, 10, pp. 180-199, (1991)
[9] Lanier, My Le, Civin, Loken, Phillips, The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes, J Immunol, 136, pp. 4480-4486, (1986)
[10] Lanier, Spits, Phillips, The developmental relationship between NK cells and T cells, Immunol Today, 13, pp. 392-395, (1992)

← 1 2 3 4 →